Literature DB >> 10210434

Hoxa-13 gene mutation results in abnormal seminal vesicle and prostate development.

C A Podlasek1, J Q Clemens, W Bushman.   

Abstract

The role of Hoxa-13 in postnatal morphogenesis of the male accessory sex organs was assessed by correlating the Hoxa-13 expression domain with phenotypic abnormalities in heterozygous Hypodactyly mutants. Hypodactyly is a naturally occurring semi-dominant mutation that results from a 50-base pair deletion in exon one of the Hoxa-13 allele. We demonstrate that Hoxa-13 is broadly expressed in the developing lower genitourinary tract and that the Hypodactyly mutation results in a specific phenotype characterized by decreased size and branching of the dorsolateral and ventral prostate and abnormal seminal vesicle morphology. This phenotype partially overlaps the genitourinary phenotype observed in Hoxd-13 deficient mice and comparison showed similar domains of Hoxa-13 and Hoxd-13 expression in the lower genitourinary tract. The similarity in expression and overlap in phenotype resulting from mutation is consistent with additive function and partial functional redundancy of Hoxa-13 and Hoxd-13 in male accessory sex organ development.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10210434

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  21 in total

1.  Posterior Hox gene expression and differential androgen regulation in the developing and adult rat prostate lobes.

Authors:  Liwei Huang; Yongbing Pu; David Hepps; David Danielpour; Gail S Prins
Journal:  Endocrinology       Date:  2006-11-30       Impact factor: 4.736

Review 2.  The role of estrogens in normal and abnormal development of the prostate gland.

Authors:  Gail S Prins; Liwei Huang; Lynn Birch; Yongbing Pu
Journal:  Ann N Y Acad Sci       Date:  2006-11       Impact factor: 5.691

3.  WNT5A selectively inhibits mouse ventral prostate development.

Authors:  Sarah Hicks Allgeier; Tien-Min Lin; Chad M Vezina; Robert W Moore; Wayne A Fritz; Shing-Yan Chiu; ChuanLi Zhang; Richard E Peterson
Journal:  Dev Biol       Date:  2008-08-29       Impact factor: 3.582

Review 4.  Molecular signaling pathways that regulate prostate gland development.

Authors:  Gail S Prins; Oliver Putz
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

Review 5.  Prostate stromal and urogenital sinus mesenchymal cell lines for investigations of stromal-epithelial interactions.

Authors:  Aubie Shaw; Steven Attia; Wade Bushman
Journal:  Differentiation       Date:  2008-05-07       Impact factor: 3.880

6.  Functional remodeling of benign human prostatic tissues in vivo by spontaneously immortalized progenitor and intermediate cells.

Authors:  Ming Jiang; Douglas W Strand; Suzanne Fernandez; Yue He; Yajun Yi; Andreas Birbach; Qingchao Qiu; Johannes Schmid; Dean G Tang; Simon W Hayward
Journal:  Stem Cells       Date:  2010-02       Impact factor: 6.277

Review 7.  Prostate organogenesis: tissue induction, hormonal regulation and cell type specification.

Authors:  Roxanne Toivanen; Michael M Shen
Journal:  Development       Date:  2017-04-15       Impact factor: 6.868

8.  A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland.

Authors:  Ryan P McMullin; Albert Dobi; Laura N Mutton; András Orosz; Shilpi Maheshwari; Cooduvalli S Shashikant; Charles J Bieberich
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

9.  HOXB13 promotes androgen independent growth of LNCaP prostate cancer cells by the activation of E2F signaling.

Authors:  Young-Rang Kim; Kyung-Jin Oh; Ra-Young Park; Nguyen Thi Xuan; Taek-Won Kang; Dong-Deuk Kwon; Chan Choi; Min Soo Kim; Kwang Il Nam; Kyu Youn Ahn; Chaeyong Jung
Journal:  Mol Cancer       Date:  2010-05-27       Impact factor: 27.401

10.  Androgenic regulation of ventral epithelial bud number and pattern in mouse urogenital sinus.

Authors:  Sarah H Allgeier; Tien-Min Lin; Robert W Moore; Chad M Vezina; Lisa L Abler; Richard E Peterson
Journal:  Dev Dyn       Date:  2010-02       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.